Finance

Lists
Why is CUE down ६.८५%?
Dive Deeper
CUE:NASDAQ
Cue Biopharma Inc
US$ १८.७६
-६.८५%
(-१.३८) 1D
US$ १८.७६
०.००% (०.००)
After hours
Closed: नोभेम्बर १०, १६:००:०१ GMT-५  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CUE...
Open
US$ १९.७३
High
US$ २०.३५
Low
US$ १८.७६
Mkt. cap
१३.६३ करोड
Avg. vol.
१.७३ लाख
Volume
१.३३ लाख
52-wk high
US$ ४५.५०
52-wk low
US$ ४.९७
EPS
-US$ २६.९९
Beta
२.७९
Shares outstanding
७२.६४ लाख
No. of employees
२९
Open
US$ १९.७३
High
US$ २०.३५
Low
US$ १८.७६
Mkt. cap
१३.६३ करोड
Avg. vol.
१.७३ लाख
Volume
१.३३ लाख
52-wk high
US$ ४५.५०
52-wk low
US$ ४.९७
EPS
-US$ २६.९९
Beta
२.७९
Shares outstanding
७२.६४ लाख
No. of employees
२९
News stories
From web sources and news partners
Investor's Business Daily
Investor's Business Daily
·
२१ मिनेट पहिले
Futures Rise, CoreWeave Jumps Late In Whipsaw Trade
Yahoo Finance
Yahoo Finance
·
१ घण्टा पहिले
Why this top Wall Street strategist isn't bullish on the S&P 500 for 2027
Mott Capital Management
Mott Capital Management
·
२९ मिनेट पहिले
The S&P 500 Has A Nvidia Problem
The Motley Fool
The Motley Fool
·
२ घण्टा पहिले
Only 2 Novembers Since 1950 Have Started Worse for the S&P 500 Than This One. Here's What Followed the Other Weak Starts.
About Cue Biopharma Inc
CEO-
Employees२९
Founded२०१४
Headquartersबोस्टन, म्यासेचुसेट्स, संयुक्त राज्य अमेरिका
SectorHealth Care
Industry-
Websitecuebiopharma.com
Analyst ratings
Based on 1 analyst giving stock ratings to CUE in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for CUE in the last 3 months
Highest
Current US$ १८.७६
US$ ८३.०० (+३४२.४३%)
Average
US$ ८३.०० (+३४२.४३%)
Lowest
US$ ८३.०० (+३४२.४३%)
Analyst
Recommendation
Action
Price target
Projected
Date
Mayank Mamtani
B. Riley Securities
Buy
Initiated
US$ ८३.००
+३४२.४%
09/18/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
२१.४९ लाख
२.१९ करोड
५६.८६ लाख
७८.७७ लाख
Cost of goods sold
४१.५४ लाख
१.५९ करोड
६३.९७ लाख
४.८५ करोड
Cost of revenue
४१.५४ लाख
१.५९ करोड
६३.९७ लाख
४.८५ करोड
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
५५.३९ लाख
४०.५२ लाख
४६.५२ लाख
४.७१ करोड
Operating expense
५५.३९ लाख
४०.५२ लाख
४६.५२ लाख
४.७१ करोड
Total operating expenses
९६.९३ लाख
२.०० करोड
१.१० करोड
९.५६ करोड
Operating income
-७५.४४ लाख
१९.५८ लाख
-५३.६३ लाख
-८.७७ करोड
Other non operating income
-
-
-
-६.५५ करोड
EBT including unusual items
-७४.४८ लाख
२०.८५ लाख
-५१.७८ लाख
-१५.३१ करोड
EBT excluding unusual items
-७३.९७ लाख
२०.६५ लाख
-५१.८८ लाख
-१५.३१ करोड
Income tax expense
-
५.०० लाख
-
-
Effective tax rate
-
२३.९८%
-
-
Other operating expenses
-
-
-
-
Net income
-७४.४८ लाख
१५.८५ लाख
-५१.७८ लाख
-१५.३१ करोड
Net profit margin
-३४६.५८%
७.२२%
-९१.०७%
-१,९४३.२१%
Earnings per share
-२.१०
-
-
-
Interest and investment income
२.२२ लाख
१.५८ लाख
१.७९ लाख
१.५७ लाख
Interest expense
-७५.०० हजार
-५१.०० हजार
-४.०० हजार
-५.०० हजार
Net interest expenses
१.४७ लाख
१.०७ लाख
१.७५ लाख
१.५२ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-७४.६४ लाख
२६.३६ लाख
-४७.९७ लाख
-८.७७ करोड
Gain or loss from assets sale
५१.०० हजार
-२०.०० हजार
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू